Highstreet Asset Management’s Elevance Health ELV Stock Holding History

Highstreet Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.41M	Sell	4,662 -1,269	-21%	-$349K	0.06%	118
2019 Q3	$1.42M	Sell	5,931 -1,474	-20%	-$404K	0.07%	108
2019 Q2	$2.09M	Buy	7,405 +4,619	+166%	+$1.26M	0.1%	86
2019 Q1	$800K	Buy	+2,786	New	+$806K	0.05%	170
2018 Q3	–	Sell	-1,764	Closed	-$420K	–	377
2018 Q2	$420K	Buy	+1,764	New	+$408K	0.03%	212
2018 Q1	–	Sell	-2,780	Closed	-$626K	–	318
2017 Q4	$626K	Buy	+2,780	New	+$592K	0.04%	169
2016 Q2	–	Sell	-4,442	Closed	-$617K	–	145
2016 Q1	$617K	Sell	4,442 -35,145	-89%	-$4.7M	0.22%	97
2015 Q4	$5.52M	Buy	39,587 +32,709	+476%	+$4.51M	1.18%	27
2015 Q3	$963K	Sell	6,878 -2,759	-29%	-$415K	0.32%	84
2015 Q2	$1.58M	Sell	9,637 -2,312	-19%	-$369K	0.46%	62
2015 Q1	$1.84M	Sell	11,949 -1,956	-14%	-$278K	0.55%	59
2014 Q4	$1.75M	Buy	13,905 +4,880	+54%	+$603K	0.44%	79
2014 Q3	$1.08M	Buy	+9,025	New	+$1.04M	0.23%	107

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Highstreet Asset Management's ELV Position: Q4 2019 in Review

Highstreet Asset Management reduced its Elevance Health (ELV) stake by 21% in Q4 2019, selling an estimated $349K and leaving 4,662 shares worth $1.41M. The position accounts for 0.06% of the portfolio, ranked #118.

Highstreet Asset Management first reported a position in ELV in Q3 2014 and has held it in 13 quarters since. The position peaked at $5.52M in Q4 2015. 1,111 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

Highstreet Asset Management held 4,662 shares of Elevance Health worth $1.41M as of Q4 2019.
Highstreet Asset Management sold 1,269 Elevance Health shares in Q4 2019, an estimated $349K.
Elevance Health made up 0.06% of Highstreet Asset Management's portfolio in Q4 2019, its #118 holding.
Highstreet Asset Management first reported a position in Elevance Health in Q3 2014 and has held it in 13 quarters since.
Highstreet Asset Management's Elevance Health position peaked at $5.52M in Q4 2015.
1,111 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.